Quantitative kinetics of [124I]FIAU in cat and man

Journal of Nuclear Medicine

Volumn 42, Issue 3, 2001, Pages 467-475

  Jacobs, A ^a   Braunlich I ^a   Graf, R ^a   Lercher, M ^a   Sakaki, T ^a   Voges, J ^a   Hesselmann, V ^a   Brandau, W ^a   Wienhard, K ^a   Heiss, W D ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

2 fluoro 2 deoxy 1 D arabinofuranosyl 5 iodouracil; Gene therapy; Molecular imaging; PET; Tracer kinetics

Indexed keywords

2' FLUORO 2' DEOXY 1 BETA DEXTRO ARABINOFURANOSYL 5 IODOURACIL; THYMIDINE DERIVATIVE; THYMIDINE KINASE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FIALURIDINE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; URACIL ARABINOSIDE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CAT; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG PURITY; DRUG UPTAKE; GLIOBLASTOMA; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; METABOLIC RATE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ANIMAL; BRAIN; BRAIN TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENZYMOLOGY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; MIDDLE AGED; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR RECURRENCE;

ANIMALS; ARABINOFURANOSYLURACIL; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CATS; GENE EXPRESSION; GENE THERAPY; GLIOBLASTOMA; HERPESVIRUS 1, HUMAN; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; THYMIDINE KINASE; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TRANSDUCTION, GENETIC;

EID: 0034745347     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Neurological disorders: An overview
2. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
3. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir: GLI328 European-Canadian Study Group
4. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir
5. Functional co-expression of HSV-1 thymidine kinase and green fluorescent protein: Implications for non-invasive imaging of transgene expression
6. Imaging the expression of transfected genes in vivo
7. Researchers and regulators reflect on first gene therapy death
8. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
9. A mutant herpes simplex vires type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography
10. Imaging transgene expression with radionuclide technologies
11. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
12. Imaging herpes vires thymidine kinase gene transfer and expression by positron emission tomography
13. Imaging adenoviral-mediated herpes vires thymidine kinase gene transfer and expression in vivo
14. The development of in vivo imaging systems to study gene expression
15. In vivo magnetic resonance imaging of transgene expression
16. Imaging HSV-1 vector mediated gene expression in vivo
17. Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU)
18. Mitochondrial toxicity of antiviral drugs
19. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B
20. Fluorinated pyrimidines: A new chance for old drugs
21. Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine
22. The in vitro evaluation of nucleoside analogues as probes for use in the noninvasive diagnosis of herpes simplex encephalitis
23. 124I
24. An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI and CT brain studies
25. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats
26. 11C-methionine PET for differential diagnosis of low-grade gliomas
27. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy
28. The ECAT EXACT HR: Performance of a new high resolution positron scanner
29. Increased amino acid transport into brain tumors measured by PET of L-t2)fluorotyrosine
30. An algorithm for least-squares estimation of nonlinear parameters
31. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
32. 14C]-1-(2-deoxy-2′-fluoro-beta-D-arabinofuranosyl) -5-iodocytosine in immunosuppressed patients with herpesvirus infections
33. Sensitive and specific radioimmunoassay for fialuridine: Initial assessment of pharmacokinetics after single oral doses to healthy volunteers
34. Pharmacological disposition and metabolic fate of 2′-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats
35. Nucleosides: 110 -Synthesis and antiherpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosylpyrimidine nucleosides
36. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells
37. Toxicity metabolism. DNA incorporation with lack of repair, and lactate production for 1-(2′-fluoro-2′-deoxy-beta-Darabinofumnosyl)-5-iodouracil in U-937 and MOLT-4 cells
38. 211At]astato-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil by a halodestannylation reaction
39. Synthesis and antiviral activity of 1VFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis
40. Quantitative autoradiographic mapping of herpes simplex vires encephalitis with a radiolabeled antiviral drug